NGF-β, NE-cells and prostatic cancer cell lines -: A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-β

被引:14
作者
Angelsen, A [1 ]
Sandvik, AK
Syversen, U
Stridsberg, M
Waldum, HL
机构
[1] Univ Trondheim Hosp, Dept Urol Surg, N-7006 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Physiol & Biomed Engn, N-7034 Trondheim, Norway
[3] Univ Trondheim Hosp, Dept Endocrinol Med, Trondheim, Norway
[4] Univ Uppsala Hosp, Dept Clin Chem, S-75185 Uppsala, Sweden
[5] Univ Trondheim Hosp, Dept Gastroenterol Med, Trondheim, Norway
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1998年 / 32卷 / 01期
关键词
NGF-beta; neuroendocrine cells; prostatic cancer cell lines;
D O I
10.1080/003655998750014611
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Neuroendocrine (NE) cells are present in both benign and malignant human prostate. However, their function is poorly understood, mainly due to the lack of suitable experimental models. The nerve growth factor-beta (NGF-beta) promotes the rat pheochromocytoma cell line PC-12 to differentiate into neuronal like cells. We have studied the effect of NGF-beta on four human prostate cancer cell lines, LNCaP, DU-145, PC-3, and TSU-pr1.NGF-beta stimulates the growth rate in all these cell lines, but does not induce a neuronal phenotype. NE tumour markers (chromogranin A [CgA] and chromogranin B[CgB]) could not be demonstrated by immunocytochemistry (CgA and CgB), Northern blotting (CgA), or ELISA techniques (CgA), neither in control nor in NGF-beta stimulated cells. Consequently, other experimental models have to be sought in the study of NE cells in the human prostate.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 59 条
[1]   PEPTIDE-HORMONEACTIVE AND SEROTONIN-IMMUNOREACTIVE TUMOR-CELLS IN CARCINOMA OF THE PROSTATE [J].
ABRAHAMSSON, PA ;
WADSTROM, LB ;
ALUMETS, J ;
FALKMER, S ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (03) :298-307
[2]   THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J].
ABRAHAMSSON, PA ;
FALKMER, S ;
FALT, K ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) :373-380
[3]   ARE NEUROENDOCRINE CELLS OF PRACTICAL VALUE AS AN INDEPENDENT PROGNOSTIC PARAMETER IN PROSTATE-CANCER [J].
ALLEN, FJ ;
VANVELDEN, DJJ ;
HEYNS, CF .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (06) :751-754
[4]  
ANGELSEN A, IN PRESS NEUROENDOCR
[5]  
APRIKIAN AG, 1993, CANCER, V71, P3952, DOI 10.1002/1097-0142(19930615)71:12<3952::AID-CNCR2820711226>3.0.CO
[6]  
2-X
[7]   THE LOW-AFFINITY P75 NERVE GROWTH-FACTOR (NGF) RECEPTOR MEDIATES NGF-INDUCED TYROSINE PHOSPHORYLATION [J].
BERG, MM ;
STERNBERG, DW ;
HEMPSTEAD, BL ;
CHAO, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7106-7110
[8]   ANDROGEN RECEPTOR STATUS IN ENDOCRINE-PARACRINE CELL-TYPES OF THE NORMAL, HYPERPLASTIC, AND NEOPLASTIC HUMAN PROSTATE [J].
BONKHOFF, H ;
STEIN, U ;
REMBERGER, K .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 423 (04) :291-294
[9]  
CHUNG LWK, 1983, PROSTATE, V4, P503, DOI 10.1002/pros.2990040509
[10]   NEUROENDOCRINE CELLS - A NEW PROGNOSTIC PARAMETER IN PROSTATE-CANCER [J].
COHEN, RJ ;
GLEZERSON, G ;
HAFFEJEE, Z .
BRITISH JOURNAL OF UROLOGY, 1991, 68 (03) :258-262